Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 102
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Nature ; 584(7821): 470-474, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32669712

RESUMEN

The rate of cell growth is crucial for bacterial fitness and drives the allocation of bacterial resources, affecting, for example, the expression levels of proteins dedicated to metabolism and biosynthesis1,2. It is unclear, however, what ultimately determines growth rates in different environmental conditions. Moreover, increasing evidence suggests that other objectives are also important3-7, such as the rate of physiological adaptation to changing environments8,9. A common challenge for cells is that these objectives cannot be independently optimized, and maximizing one often reduces another. Many such trade-offs have indeed been hypothesized on the basis of qualitative correlative studies8-11. Here we report a trade-off between steady-state growth rate and physiological adaptability in Escherichia coli, observed when a growing culture is abruptly shifted from a preferred carbon source such as glucose to fermentation products such as acetate. These metabolic transitions, common for enteric bacteria, are often accompanied by multi-hour lags before growth resumes. Metabolomic analysis reveals that long lags result from the depletion of key metabolites that follows the sudden reversal in the central carbon flux owing to the imposed nutrient shifts. A model of sequential flux limitation not only explains the observed trade-off between growth and adaptability, but also allows quantitative predictions regarding the universal occurrence of such tradeoffs, based on the opposing enzyme requirements of glycolysis versus gluconeogenesis. We validate these predictions experimentally for many different nutrient shifts in E. coli, as well as for other respiro-fermentative microorganisms, including Bacillus subtilis and Saccharomyces cerevisiae.


Asunto(s)
Adaptación Fisiológica , Ambiente , Escherichia coli/crecimiento & desarrollo , Escherichia coli/metabolismo , Acetatos/metabolismo , Bacillus subtilis/citología , Bacillus subtilis/crecimiento & desarrollo , Bacillus subtilis/metabolismo , División Celular , Escherichia coli/enzimología , Escherichia coli/genética , Fermentación , Gluconeogénesis , Glucosa/metabolismo , Glucólisis , Metabolómica , Modelos Biológicos , Mutación , Saccharomyces cerevisiae/citología , Saccharomyces cerevisiae/crecimiento & desarrollo , Saccharomyces cerevisiae/metabolismo
2.
PLoS Biol ; 19(4): e3001194, 2021 04.
Artículo en Inglés | MEDLINE | ID: mdl-33872303

RESUMEN

Persisters represent a small subpopulation of non- or slow-growing bacterial cells that are tolerant to killing by antibiotics. Despite their prominent role in the recalcitrance of chronic infections to antibiotic therapy, the mechanism of their formation has remained elusive. We show that sorted cells of Escherichia coli with low levels of energy-generating enzymes are better able to survive antibiotic killing. Using microfluidics time-lapse microscopy and a fluorescent reporter for in vivo ATP measurements, we find that a subpopulation of cells with a low level of ATP survives killing by ampicillin. We propose that these low ATP cells are formed stochastically as a result of fluctuations in the abundance of energy-generating components. These findings point to a general "low energy" mechanism of persister formation.


Asunto(s)
Bacterias/metabolismo , Fenómenos Fisiológicos Bacterianos/efectos de los fármacos , Farmacorresistencia Bacteriana Múltiple , Antibacterianos/farmacología , Bacterias/efectos de los fármacos , Bacterias/genética , Bacterias/crecimiento & desarrollo , Ciclo del Ácido Cítrico/efectos de los fármacos , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Metabolismo Energético/efectos de los fármacos , Metabolismo Energético/fisiología , Escherichia coli/efectos de los fármacos , Escherichia coli/crecimiento & desarrollo , Escherichia coli/metabolismo , Pruebas de Sensibilidad Microbiana , Viabilidad Microbiana/efectos de los fármacos , Organismos Modificados Genéticamente
3.
Cell ; 139(6): 1157-69, 2009 Dec 11.
Artículo en Inglés | MEDLINE | ID: mdl-20005808

RESUMEN

The insulin/insulin growth factor (IGF) signaling (IIS) pathway is a key regulator of aging of worms, flies, mice, and likely humans. Delayed aging by IIS reduction protects the nematode C. elegans from toxicity associated with the aggregation of the Alzheimer's disease-linked human peptide, Abeta. We reduced IGF signaling in Alzheimer's model mice and discovered that these animals are protected from Alzheimer's-like disease symptoms, including reduced behavioral impairment, neuroinflammation, and neuronal loss. This protection is correlated with the hyperaggregation of Abeta leading to tightly packed, ordered plaques, suggesting that one aspect of the protection conferred by reduced IGF signaling is the sequestration of soluble Abeta oligomers into dense aggregates of lower toxicity. These findings indicate that the IGF signaling-regulated mechanism that protects from Abeta toxicity is conserved from worms to mammals and point to the modulation of this signaling pathway as a promising strategy for the development of Alzheimer's disease therapy.


Asunto(s)
Factor I del Crecimiento Similar a la Insulina/metabolismo , Longevidad , Transducción de Señal , Enfermedad de Alzheimer/metabolismo , Enfermedad de Alzheimer/fisiopatología , Péptidos beta-Amiloides/metabolismo , Animales , Humanos , Masculino , Ratones , Ratones Transgénicos , Presenilina-1/genética , Presenilina-1/metabolismo , Receptor IGF Tipo 1/metabolismo
4.
Nat Methods ; 17(1): 93-100, 2020 01.
Artículo en Inglés | MEDLINE | ID: mdl-31768062

RESUMEN

Single-cell genetic screens can be incredibly powerful, but current high-throughput platforms do not track dynamic processes, and even for non-dynamic properties they struggle to separate mutants of interest from phenotypic outliers of the wild-type population. Here we introduce SIFT, single-cell isolation following time-lapse imaging, to address these limitations. After imaging and tracking individual bacteria for tens of consecutive generations under tightly controlled growth conditions, cells of interest are isolated and propagated for downstream analysis, free of contamination and without genetic or physiological perturbations. This platform can characterize tens of thousands of cell lineages per day, making it possible to accurately screen complex phenotypes without the need for barcoding or genetic modifications. We applied SIFT to identify a set of ultraprecise synthetic gene oscillators, with circuit variants spanning a 30-fold range of average periods. This revealed novel design principles in synthetic biology and demonstrated the power of SIFT to reliably screen diverse dynamic phenotypes.


Asunto(s)
Separación Celular/métodos , Proteínas de Escherichia coli/metabolismo , Escherichia coli/aislamiento & purificación , Ensayos Analíticos de Alto Rendimiento/métodos , Análisis de la Célula Individual/métodos , Imagen de Lapso de Tiempo/instrumentación , Imagen de Lapso de Tiempo/métodos , Rastreo Celular/métodos , Escherichia coli/genética , Escherichia coli/metabolismo , Proteínas de Escherichia coli/genética , Biblioteca de Genes , Genes Sintéticos , Procesamiento de Imagen Asistido por Computador , Microfluídica/métodos
5.
Nature ; 547(7663): 293-297, 2017 07 19.
Artículo en Inglés | MEDLINE | ID: mdl-28726822

RESUMEN

Many fine-scale features of ribosomes have been explained in terms of function, revealing a molecular machine that is optimized for error-correction, speed and control. Here we demonstrate mathematically that many less well understood, larger-scale features of ribosomes-such as why a few ribosomal RNA molecules dominate the mass and why the ribosomal protein content is divided into 55-80 small, similarly sized segments-speed up their autocatalytic production.


Asunto(s)
Biocatálisis , Ribosomas/metabolismo , Conformación de Ácido Nucleico , Biosíntesis de Proteínas , ARN Ribosómico/química , ARN Ribosómico/genética , ARN Ribosómico/metabolismo , Proteínas Ribosómicas/química , Proteínas Ribosómicas/metabolismo , Ribosomas/química
6.
Nature ; 538(7626): 514-517, 2016 10 27.
Artículo en Inglés | MEDLINE | ID: mdl-27732583

RESUMEN

Synthetically engineered genetic circuits can perform a wide variety of tasks but are generally less accurate than natural systems. Here we revisit the first synthetic genetic oscillator, the repressilator, and modify it using principles from stochastic chemistry in single cells. Specifically, we sought to reduce error propagation and information losses, not by adding control loops, but by simply removing existing features. We show that this modification created highly regular and robust oscillations. Furthermore, some streamlined circuits kept 14 generation periods over a range of growth conditions and kept phase for hundreds of generations in single cells, allowing cells in flasks and colonies to oscillate synchronously without any coupling between them. Our results suggest that even the simplest synthetic genetic networks can achieve a precision that rivals natural systems, and emphasize the importance of noise analyses for circuit design in synthetic biology.


Asunto(s)
Relojes Biológicos/genética , Escherichia coli/genética , Regulación Bacteriana de la Expresión Génica , Redes Reguladoras de Genes/genética , Genes Sintéticos/genética , Ingeniería Genética , Modelos Genéticos , Biología Sintética/métodos , Proyectos de Investigación
7.
Nucleic Acids Res ; 48(14): 8165-8177, 2020 08 20.
Artículo en Inglés | MEDLINE | ID: mdl-32609820

RESUMEN

In synthetic circuits, CRISPR-Cas systems have been used effectively for endpoint changes from an initial state to a final state, such as in logic gates. Here, we use deactivated Cas9 (dCas9) and deactivated Cas12a (dCas12a) to construct dynamic RNA ring oscillators that cycle continuously between states over time in bacterial cells. While our dCas9 circuits using 103-nt guide RNAs showed irregular fluctuations with a wide distribution of peak-to-peak period lengths averaging approximately nine generations, a dCas12a oscillator design with 40-nt CRISPR RNAs performed much better, having a strongly repressed off-state, distinct autocorrelation function peaks, and an average peak-to-peak period length of ∼7.5 generations. Along with free-running oscillator circuits, we measure repression response times in open-loop systems with inducible RNA steps to compare with oscillator period times. We track thousands of cells for 24+ h at the single-cell level using a microfluidic device. In creating a circuit with nearly translationally independent behavior, as the RNAs control each others' transcription, we present the possibility for a synthetic oscillator generalizable across many organisms and readily linkable for transcriptional control.


Asunto(s)
Proteína 9 Asociada a CRISPR/metabolismo , Sistemas CRISPR-Cas , Microfluídica/métodos , Periodicidad , ARN Guía de Kinetoplastida/metabolismo , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , Proteína 9 Asociada a CRISPR/genética , Proteínas Asociadas a CRISPR/genética , Proteínas Asociadas a CRISPR/metabolismo , Endodesoxirribonucleasas/genética , Endodesoxirribonucleasas/metabolismo , Escherichia coli , Microfluídica/instrumentación , ARN Guía de Kinetoplastida/genética , Análisis de la Célula Individual/instrumentación , Análisis de la Célula Individual/métodos
8.
EMBO J ; 36(19): 2856-2869, 2017 10 02.
Artículo en Inglés | MEDLINE | ID: mdl-28838935

RESUMEN

Entry into sporulation in Bacillus subtilis is governed by a phosphorelay in which phosphoryl groups from a histidine kinase are successively transferred via relay proteins to the response regulator Spo0A. Spo0A~P, in turn, sets in motion events that lead to asymmetric division and activation of the cell-specific transcription factor σF, a hallmark for entry into sporulation. Here, we have used a microfluidics-based platform to investigate the activation of Spo0A and σF in individual cells held under constant, sporulation-inducing conditions. The principal conclusions were that: (i) activation of σF occurs with an approximately constant probability after adaptation to conditions of nutrient limitation; (ii) activation of σF is tightly correlated with, and preceded by, Spo0A~P reaching a high threshold level; (iii) activation of Spo0A takes place abruptly just prior to asymmetric division; and (iv) the primary source of noise in the activation of Spo0A is the phosphorelay. We propose that cells exhibit a constant probability of attaining a high threshold level of Spo0A~P due to fluctuations in the flux of phosphoryl groups through the phosphorelay.


Asunto(s)
Bacillus subtilis/fisiología , Proteínas Bacterianas/metabolismo , Esporas Bacterianas/metabolismo , Factores de Transcripción/metabolismo , Bacillus subtilis/genética , Bacillus subtilis/metabolismo , Proteínas Bacterianas/genética , Regulación Bacteriana de la Expresión Génica , Histidina Quinasa/metabolismo , Redes y Vías Metabólicas/genética , Redes y Vías Metabólicas/fisiología , Técnicas Analíticas Microfluídicas , Fosfatos/metabolismo , Fosforilación , Proteínas Quinasas/metabolismo , Esporas Bacterianas/genética , Transcripción Genética
9.
Small ; 17(52): e2104009, 2021 12.
Artículo en Inglés | MEDLINE | ID: mdl-34845827

RESUMEN

Here, a novel microfluidic test kit combining ultrahigh throughput hydrodynamic filtration and sandwich immunoassay is reported. Specifically, nano and microbeads coated with two different, noncompetitive antibodies, are used to capture the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid (N) proteins simultaneously, forming larger complexes. Microfluidic filtration discards free nanobeads but retains antigen-bridged complexes in the observation zone, where a display of red color indicates the presence of antigen in the sample. This testing platform exhibits high throughput separation (<30 s) and enrichment of antigen that exceeds the traditional lateral flow assays or microfluidic assays, with a low limit of detection (LoD) < 100 copies mL-1 . In two rounds of clinical trials conducted in December 2020 and August 2021, the assays demonstrate high sensitivities of 95.4% and 100%, respectively, which proves this microfluidic test kit is capable of detecting SARS-CoV-2 virus variants evolved over significant periods of time. Furthermore, the mass-produced chip can be fabricated at a cost of $0.98/test and the robust design allows the chip to be reused for over 50 times. All of these features make the microfluidic test kit particularly suitable for areas with inadequate medical infrastructure and a shortage of laboratory resources.


Asunto(s)
COVID-19 , SARS-CoV-2 , Humanos , Inmunoensayo , Microfluídica , Autoevaluación , Sensibilidad y Especificidad
10.
Pharm Res ; 38(8): 1369-1385, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-34272643

RESUMEN

PURPOSE: The anorectic effect of PYY3-36 makes it a potential pharmacological weight loss treatment. Modifications of the endogenous peptide to obtain commercially attractive pharmacological and biophysical stability properties are examined. METHODS: Half-life extended PYY3-36 analogues were prepared and examined regarding Y2-receptor potency as well as biophysical and stability properties. RESULTS: Deamidation of asparagine in position 18 and 29 was observed upon incubation at 37°C. Asparagine in position 18 - but not position 29 - could be substituted to glutamine without detrimental effects on Y2-receptor potency. Covalent dimers were formed via the phenol impurity benzoquinone reacting with two N-terminal residues (Isoleucine-Lysine). Both residues had to be modified to suppress dimerization, which could be done without negatively affecting Y2-receptor potency or other stability/biophysical properties. Introduction of half-life extending modifications in position 30 and 35 eliminated aggregation at 37°C without negatively affecting other stability properties. Placement of a protracting moiety (fatty acid) in the receptor-binding C-terminal region reduced Y2-receptor potency substantially, whereas only minor effects of protractor position were observed on structural, biophysical or stability properties. Lipidated PYY3-36 analogues formed oligomers of various sizes depending on primary structure and solution conditions. CONCLUSIONS: By rational design, a chemically and physically stable Y2-receptor selective, half-life extended PYY3-36 peptide has been developed.


Asunto(s)
Fragmentos de Péptidos/química , Péptido YY/química , Receptores de Neuropéptido Y/agonistas , Asparagina/química , Desarrollo de Medicamentos , Células HEK293 , Humanos , Fragmentos de Péptidos/farmacología , Péptido YY/farmacología
11.
J Pathol ; 250(2): 183-194, 2020 02.
Artículo en Inglés | MEDLINE | ID: mdl-31621921

RESUMEN

The genetics underlying thyroid cancer dedifferentiation is only partly understood and has not yet been characterised using comprehensive pan-genomic analyses. We investigated a unique case with synchronous follicular thyroid carcinoma (FTC), poorly differentiated thyroid carcinoma (PDTC), and anaplastic thyroid carcinoma (ATC), as well as regional lymph node metastases from the PDTC and ATC from a single patient using whole-genome sequencing (WGS). The FTC displayed mutations in CALR, RB1, and MSH2, and the PDTC exhibited mutations in TP53, DROSHA, APC, TERT, and additional DNA repair genes - associated with an immense increase in sub-clonal somatic mutations. All components displayed an overrepresentation of C>T transitions with associated microsatellite instability (MSI) in the PDTC and ATC, with borderline MSI in the FTC. Clonality analyses pinpointed a shared ancestral clone enriched for mutations in TP53-associated regulation of DNA repair and identified important sub-clones for each tumour component already present in the corresponding preceding lesion. This genomic characterisation of the natural progression of thyroid cancer reveals several novel genes of interest for future studies. Moreover, the findings support the theory of a stepwise dedifferentiation process and suggest that defects in DNA repair could play an important role in the clonal evolution of thyroid cancer. © 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.


Asunto(s)
Reparación del ADN/genética , Neoplasias Primarias Múltiples/genética , Carcinoma Anaplásico de Tiroides/genética , Neoplasias de la Tiroides/genética , Anciano , Desdiferenciación Celular/genética , Variaciones en el Número de Copia de ADN , Análisis Mutacional de ADN/métodos , ADN de Neoplasias/genética , Progresión de la Enfermedad , Femenino , Frecuencia de los Genes , Humanos , Metástasis Linfática , Inestabilidad de Microsatélites , Mutación , Neoplasias Primarias Múltiples/patología , Carcinoma Anaplásico de Tiroides/patología , Carcinoma Anaplásico de Tiroides/secundario , Neoplasias de la Tiroides/patología , Secuenciación Completa del Genoma/métodos
12.
Proc Natl Acad Sci U S A ; 115(33): E7710-E7719, 2018 08 14.
Artículo en Inglés | MEDLINE | ID: mdl-30061394

RESUMEN

Cell-autonomous and cell-nonautonomous mechanisms of neurodegeneration appear to occur in the proteinopathies, including Alzheimer's and Parkinson's diseases. However, how neuronal toxicity is generated from misfolding-prone proteins secreted by nonneuronal tissues and whether modulating protein aggregate levels at distal locales affects the degeneration of postmitotic neurons remains unknown. We generated and characterized animal models of the transthyretin (TTR) amyloidoses that faithfully recapitulate cell-nonautonomous neuronal proteotoxicity by expressing human TTR in the Caenorhabditis elegans muscle. We identified sensory neurons with affected morphological and behavioral nociception-sensing impairments. Nonnative TTR oligomer load and neurotoxicity increased following inhibition of TTR degradation in distal macrophage-like nonaffected cells. Moreover, reducing TTR levels by RNAi or by kinetically stabilizing natively folded TTR pharmacologically decreased TTR aggregate load and attenuated neuronal dysfunction. These findings reveal a critical role for in trans modulation of aggregation-prone degradation that directly affects postmitotic tissue degeneration observed in the proteinopathies.


Asunto(s)
Proteínas de Caenorhabditis elegans/metabolismo , Caenorhabditis elegans/metabolismo , Prealbúmina/metabolismo , Agregado de Proteínas , Neuropatías Amiloides/genética , Neuropatías Amiloides/metabolismo , Animales , Animales Modificados Genéticamente , Caenorhabditis elegans/citología , Caenorhabditis elegans/genética , Proteínas de Caenorhabditis elegans/genética , Humanos , Prealbúmina/genética , Agregación Patológica de Proteínas/genética , Agregación Patológica de Proteínas/metabolismo
13.
Angew Chem Int Ed Engl ; 60(15): 8268-8275, 2021 04 06.
Artículo en Inglés | MEDLINE | ID: mdl-33448563

RESUMEN

The two gut hormones GLP-1 and PYY3-36 , which are both secreted from the L-cells upon food stimuli, have a stronger inhibitory effect on food intake when they are combined, compared to their individual effects as single agonists. Although they are not homologous and share no sequence similarity, we show that a GLP-1 analogue can be designed to exhibit potent activity on both the Y2 and GLP-1 receptors. Dual acting hybrid analogues were realized by designing truncated and potent Y2 receptor PYY analogues, followed by integrating the critical residues into GLP-1. In this study, we show that one of these dual acting agonists acutely reduces food intake significantly more than the respective mono-agonist counterparts.


Asunto(s)
Diseño de Fármacos , Péptido 1 Similar al Glucagón/farmacología , Receptor del Péptido 1 Similar al Glucagón/agonistas , Fragmentos de Péptidos/farmacología , Péptido YY/farmacología , Receptores de la Hormona Gastrointestinal/agonistas , Cristalografía por Rayos X , Péptido 1 Similar al Glucagón/síntesis química , Péptido 1 Similar al Glucagón/química , Humanos , Modelos Moleculares , Fragmentos de Péptidos/síntesis química , Fragmentos de Péptidos/química , Péptido YY/síntesis química , Péptido YY/química
14.
Am J Physiol Endocrinol Metab ; 318(1): E72-E86, 2020 01 01.
Artículo en Inglés | MEDLINE | ID: mdl-31743040

RESUMEN

The possibility to use leptin therapeutically for lowering glucose levels in patients with type 1 diabetes has attracted interest. However, earlier animal models of type 1 diabetes are severely catabolic with very low endogenous leptin levels, unlike most patients with diabetes. Here, we aim to test glucose-lowering effects of leptin in novel, more human-like murine models. We examined the glucose-lowering potential of leptin in diabetic models of two types: streptozotocin-treated mice and mice treated with the insulin receptor antagonist S961. To prevent hypoleptinemia, we used combinations of thermoneutral temperature and high-fat feeding. Leptin fully normalized hyperglycemia in standard chow-fed streptozotocin-treated diabetic mice. However, more humanized physiological conditions (high-fat diets or thermoneutral temperatures) that increased adiposity - and thus also leptin levels - in the diabetic mice abrogated the effects of leptin, i.e., the mice developed leptin resistance also in this respect. The glucose-lowering effect of leptin was not dependent on the presence of the uncoupling protein-1 and was not associated with alterations in plasma insulin, insulin-like growth factor 1, food intake or corticosterone but fully correlated with decreased plasma glucagon levels and gluconeogenesis. An important implication of these observations is that the therapeutic potential of leptin as an additional treatment in patients with type 1 diabetes is probably limited. This is because such patients are treated with insulin and do not display low leptin levels. Thus, the potential for a glucose-lowering effect of leptin would already have been attained with standard insulin therapy, and further effects on blood glucose level through additional leptin cannot be anticipated.


Asunto(s)
Glucemia/efectos de los fármacos , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Tipo 1/metabolismo , Leptina/metabolismo , Tejido Adiposo Pardo/metabolismo , Tejido Adiposo Blanco/metabolismo , Animales , Glucemia/metabolismo , Corticosterona/metabolismo , Modelos Animales de Enfermedad , Ingestión de Alimentos , Glucagón/metabolismo , Gluconeogénesis , Humanos , Insulina/metabolismo , Factor I del Crecimiento Similar a la Insulina/metabolismo , Leptina/farmacología , Ratones , Ratones Noqueados , Consumo de Oxígeno , Péptidos/farmacología , Ácido Pirúvico/metabolismo , Receptor de Insulina/antagonistas & inhibidores , Transcriptoma , Proteína Desacopladora 1/genética , Proteína Desacopladora 1/metabolismo
15.
Annu Rev Microbiol ; 69: 381-403, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26332088

RESUMEN

Microbes transiently differentiate into distinct, specialized cell types to generate functional diversity and cope with changing environmental conditions. Though alternate programs often entail radically different physiological and morphological states, recent single-cell studies have revealed that these crucial decisions are often left to chance. In these cases, the underlying genetic circuits leverage the intrinsic stochasticity of intracellular chemistry to drive transition between states. Understanding how these circuits transform transient gene expression fluctuations into lasting phenotypic programs will require a combination of quantitative modeling and extensive, time-resolved observation of switching events in single cells. In this article, we survey microbial cell fate decisions demonstrated to involve a random element, describe theoretical frameworks for understanding stochastic switching between states, and highlight recent advances in microfluidics that will enable characterization of key dynamic features of these circuits.


Asunto(s)
Bacterias/citología , Fenómenos Fisiológicos Bacterianos , Bacterias/química , Bacterias/clasificación , Bacterias/genética , Análisis de la Célula Individual
16.
Toxicol Appl Pharmacol ; 404: 115152, 2020 10 01.
Artículo en Inglés | MEDLINE | ID: mdl-32726590

RESUMEN

Energy metabolism and reproduction are closely linked and reciprocally regulated. The detrimental effect of underweight on reproduction complicates the safety evaluation of anti-obesity drugs, making it challenging to distinguish pathological changes mediated through the intended drug-induced weight loss from direct drug effects on reproductive organs. Four-weeks dosing of normal weight Sprague Dawley rats with a glucagon-like peptide 1 (GLP-1)/glucagon receptor co-agonist induced a robust weight loss, accompanied by histological findings in prostate, seminal vesicles, mammary glands, uterus/cervix and vagina. Characterization of the hypothalamus-pituitary-gonadal (HPG) axis in male rats revealed reduced hypothalamic Kiss1 mRNA levels and decreased serum luteinizing hormone (LH) and testosterone concentrations following co-agonist dosing. These alterations resemble hypogonadotropic hypogonadism typically seen in adverse energy deprived conditions, like chronic food restriction. Concomitant daily administration of kisspeptin-52 from day 21 to the end of the four-week co-agonist dosing period evoked LH and testosterone responses without normalizing histological findings. This incomplete rescue by kisspeptin-52 may be due to the rather short kisspeptin-52 treatment period combined with a desensitization observed on testosterone responses. Concomitant leptin treatment from day 21 did not reverse co-agonist induced changes in HPG axis activity. Furthermore, a single co-agonist injection in male rats slightly elevated LH levels but left testosterone unperturbed, thereby excluding a direct acute inhibitory effect on the HPG axis. Our data suggest that the reproductive phenotype after repeated co-agonist administration was driven by the intended weight loss, however, we cannot exclude a direct organ related effect in chronically treated rats.


Asunto(s)
Fármacos Antiobesidad/farmacología , Sistema Hipotálamo-Hipofisario/efectos de los fármacos , Kisspeptinas/farmacología , Testículo/efectos de los fármacos , Animales , Kisspeptinas/administración & dosificación , Masculino , Ratas , Ratas Sprague-Dawley , Testículo/metabolismo , Delgadez , Pérdida de Peso/efectos de los fármacos
18.
PLoS Genet ; 13(7): e1006901, 2017 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-28727759

RESUMEN

Bacteria use a variety of stress-sensing systems to sense and respond to diverse stressors and to ensure their survival under adverse conditions. The gram-positive bacterium Bacillus subtilis responds to energy stress (ATP depletion) and to environmental stressors using two distinct stress-sensing pathways that converge on the alternative sigma factor σB to provoke a general stress response. Past efforts to study the σB stress response in bulk culture and on agarose pads were unable to visualize the responses of individual cells under tightly controlled conditions for extended periods of time. Here we use a microfluidics-based strategy to discern the basic features of σB activation in single cells in response to energy and environmental stress, both immediately upon stressor exposure and for tens of generations thereafter. Upon energy stress at various levels of stressor, cells exhibited fast, transient, and amplitude-modulated responses but not frequency modulation as previously reported. Upon environmental stress, which is mediated by the stressosome complex, wild-type cells primarily exhibited a transient and amplitude-modulated response. However, mutant cells producing only one of the four paralogous RsbR stressosome proteins showed striking and previously unseen differences. Whereas RsbRA-only cells mimicked the wild type, RsbRC-only cells displayed a slower but sustained overall response composed of repeated activation events in single cells.


Asunto(s)
Proteínas Bacterianas/genética , Metabolismo Energético/genética , Fosfoproteínas/genética , Proteínas Serina-Treonina Quinasas/genética , Factor sigma/genética , Estrés Fisiológico/genética , Adenosina Trifosfato/genética , Bacillus subtilis/genética , Bacillus subtilis/metabolismo , Interacción Gen-Ambiente , Técnicas Analíticas Microfluídicas/métodos , Análisis de la Célula Individual/métodos
19.
Phys Rev Lett ; 123(10): 108101, 2019 Sep 06.
Artículo en Inglés | MEDLINE | ID: mdl-31573304

RESUMEN

Nonequilibrium stochastic reaction networks are commonly found in both biological and nonbiological systems, but have remained hard to analyze because small differences in rate functions or topology can change the dynamics drastically. Here, we conjecture exact quantitative inequalities that relate the extent of fluctuations in connected components, for various network topologies. Specifically, we find that regardless of how two components affect each other's production rates, it is impossible to suppress fluctuations below the uncontrolled equivalents for both components: one must increase its fluctuations for the other to be suppressed. For systems in which components control each other in ringlike structures, it appears that fluctuations can only be suppressed in one component if all other components instead increase fluctuations, compared to the case without control. Even the general N-component system-with arbitrary connections and parameters-must have at least one component with increased fluctuations to reduce fluctuations in others. In connected reaction networks it thus appears impossible to reduce the statistical uncertainty in all components, regardless of the control mechanisms or energy dissipation.

20.
Nature ; 503(7477): 481-486, 2013 Nov 28.
Artículo en Inglés | MEDLINE | ID: mdl-24256735

RESUMEN

Genetically identical cells sharing an environment can display markedly different phenotypes. It is often unclear how much of this variation derives from chance, external signals, or attempts by individual cells to exert autonomous phenotypic programs. By observing thousands of cells for hundreds of consecutive generations under constant conditions, we dissect the stochastic decision between a solitary, motile state and a chained, sessile state in Bacillus subtilis. We show that the motile state is 'memoryless', exhibiting no autonomous control over the time spent in the state. In contrast, the time spent as connected chains of cells is tightly controlled, enforcing coordination among related cells in the multicellular state. We show that the three-protein regulatory circuit governing the decision is modular, as initiation and maintenance of chaining are genetically separable functions. As stimulation of the same initiating pathway triggers biofilm formation, we argue that autonomous timing allows a trial commitment to multicellularity that external signals could extend.


Asunto(s)
Bacillus subtilis/citología , Bacillus subtilis/fisiología , Bacillus subtilis/genética , Modelos Biológicos , Movimiento , Fenotipo , Procesos Estocásticos , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA